| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/10/2006 | US20060177868 Method of spotting probe on solid support, probe array and method of manufacturing thereof, and method of detecting target substance and method of identifying structure of target substance using probe array |
| 08/10/2006 | US20060177865 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 08/10/2006 | US20060177862 Ribosome display |
| 08/10/2006 | US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177846 Method and apparatus for design and display of primers |
| 08/10/2006 | US20060177835 A dual oligonucleotide hybridization assay combining the advantages of the direct detection assays (e.g., easy quantification and minimal risk of carry-over contamination) with the specificity provided by a dual oligonucleotide hybridization assay; site-specific nuclease cleavage by a variety of enzymes |
| 08/10/2006 | US20060177825 Global analysis of transposable elements as molecular markers of the developmental potential of stem cells |
| 08/10/2006 | US20060177822 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 08/10/2006 | US20060177813 Novel high-throughput screening method of drug for bioactive protein |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177465 Polypeptide antigens of streptococcus pneumoniae pathogen useful as vaccine for prophylaxis, diagnostic or treatment of streptococcal infection |
| 08/10/2006 | US20060177464 Methods and compositions involving LcrV proteins |
| 08/10/2006 | US20060177463 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide |
| 08/10/2006 | US20060177462 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 08/10/2006 | US20060177461 Stress proteins and uses therefor |
| 08/10/2006 | US20060177460 Administering to a patient a stress protein joined via a peptide bond to a melanoma antigen to induce or enhanc an immune response against the melanoma antigen |
| 08/10/2006 | US20060177458 Compositions of CpG and saponin adjuvants and uses thereof |
| 08/10/2006 | US20060177456 Apo-2 receptor antibodies |
| 08/10/2006 | US20060177455 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 08/10/2006 | US20060177448 Inhibiting HER2 shedding with matrix metalloprotease antagonists |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177440 Compositions and methods for detection of antibody binding to cells |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177427 DNA coding for endo-beta-galactosidase |
| 08/10/2006 | US20060177423 Composition and method for killing of tumours |
| 08/10/2006 | US20060177422 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide |
| 08/10/2006 | DE60024843T2 Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten Containing vaccines for oral use the liposome and a nucleic acid |
| 08/10/2006 | CA2827515A1 Site-specific serine recombinases and methods of their use |
| 08/10/2006 | CA2610632A1 Genetically engineered swine influenza virus and uses thereof |
| 08/10/2006 | CA2597171A1 Antibodies to oncostatin m receptor |
| 08/10/2006 | CA2597040A1 Hiv tat-cd4 hybrid molecules and methods of use thereof |
| 08/10/2006 | CA2596929A1 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 08/10/2006 | CA2596852A1 Method for evaluating quality of beef such as taste and texture through genotyping |
| 08/10/2006 | CA2596758A1 Method of generating translationally active linear dna molecules and use thereof in array formats |
| 08/10/2006 | CA2596731A1 Nucleic acid constructs |
| 08/10/2006 | CA2596715A1 Screening method |
| 08/10/2006 | CA2596711A1 Rnai expression constructs |
| 08/10/2006 | CA2596698A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 08/10/2006 | CA2596697A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | CA2596687A1 Method for detecting p53 dysfunction, method for molecular diagnosis of cancer and method for evaluating compound effective in treating cancer |
| 08/10/2006 | CA2596674A1 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596672A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | CA2596661A1 Novel hydrophobin fusion products, production and use thereof |
| 08/10/2006 | CA2596588A1 Nucleic acid silencing of huntington's disease gene |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2596332A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | CA2595985A1 Transcription regulating nucleotide sequence from solanaceae triose-phosphate translocator genes and their use in plant expression cassettes |
| 08/10/2006 | CA2595929A1 Site-specific serine recombinases and methods of their use |
| 08/10/2006 | CA2595901A1 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 08/10/2006 | CA2595792A1 Cd20 antibody variants and uses thereof |
| 08/10/2006 | CA2595790A1 Rnai-mediated inhibition of ocular hypertension targets |
| 08/10/2006 | CA2595678A1 Rnai-mediated inhibition of ocular targets |
| 08/10/2006 | CA2594636A1 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | CA2592449A1 Recombinant microorganisms for increased production of organic acids |
| 08/10/2006 | CA2583306A1 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
| 08/09/2006 | EP1688504A1 Screening method with the use of tbk1 knockout mouse |
| 08/09/2006 | EP1688500A2 Overexpression of phytase genes in yeast systems |
| 08/09/2006 | EP1688499A1 Alcohol-aldehyd-dehydrogenases |
| 08/09/2006 | EP1688498A1 A recombinant protein with cancer suppression action, its encoding gene and use |
| 08/09/2006 | EP1688497A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688496A2 Regulation of human P2Y1-like G protein-coupled receptor |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688494A1 Monkey npy y4 recepotr and method of evaluating compound |
| 08/09/2006 | EP1688493A1 Method of detecting genetic polymorphism |
| 08/09/2006 | EP1688491A1 Novel plasmids and utilization thereof |
| 08/09/2006 | EP1688490A1 Dose-dependent promoter originating in humans |
| 08/09/2006 | EP1688489A1 Method of selecting genomic dna fragment |
| 08/09/2006 | EP1688488A1 Bispecific antibody substituting for functional proteins |
| 08/09/2006 | EP1688487A1 Method of controlling transcription of insulin gene |
| 08/09/2006 | EP1688486A1 Antibacterial peptide and utilization of the same |
| 08/09/2006 | EP1688480A2 NOVEL ACETOACETYL-CoA REDUCTASE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL |
| 08/09/2006 | EP1688437A1 Antibody composition specifically binding to il-5 receptor |
| 08/09/2006 | EP1688436A1 Composition of antibody capable of specifically binding ccr4 |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688433A1 Antibody composition specifically binding to ganglioside gm2 |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688036A1 Transgenic nonhuman mammal |
| 08/09/2006 | EP1688035A1 Hyperlipemia/ hyperalbuminemia model animal |
| 08/09/2006 | EP1687449A2 Antisense modulation of kinesin-like 1 expression |
| 08/09/2006 | EP1687438A2 Methods and compositions for altering seed phenotypes |
| 08/09/2006 | EP1687435A1 Insect resistance using inhibition of gene expression |
| 08/09/2006 | EP1687434A1 Expression of plastid-targeted polypeptides in plants |
| 08/09/2006 | EP1687433A1 Method for stable gene-amplification in a bacterial host cell |
| 08/09/2006 | EP1687432A2 Compositions and methods for synergistic induction of antitumor immunity |
| 08/09/2006 | EP1687431A2 Compositions and methods for screening pro-apoptotic compounds |
| 08/09/2006 | EP1687430A1 Immunization against chlamydia infection |
| 08/09/2006 | EP1687429A2 Promoters functional in plant plastids |
| 08/09/2006 | EP1687428A1 Processes for making acylated insulin |
| 08/09/2006 | EP1687427A2 Methods for modulating neuronal responses |
| 08/09/2006 | EP1687426A2 Antiangiogenicpeptides for treating or preventing endometriosis |
| 08/09/2006 | EP1687425A1 Nucleic acid primers for detecting serpula lacrymans dry rot fungus, and methods and test kit in which they are used |
| 08/09/2006 | EP1687424A1 A rapid and low cost method for isolating nucleic acid |
| 08/09/2006 | EP1687423A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/09/2006 | EP1687422A2 Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid |
| 08/09/2006 | EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |